In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

An investigation of factors that best predict incremental shuttle walk test distance in cardiac rehabilitation patients

Session Poster session 2

Speaker Jassas Alotaibi

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2016

  • Topic : preventive cardiology
  • Sub-topic : Cardiovascular Rehabilitation
  • Session type : Poster Session

Authors : J Alotaibi (York,GB), PD Doherty (York,GB)

J Alotaibi1 , PD Doherty1 , 1University Of York, Health Sciences - York - United Kingdom ,

European Journal of Preventive Cardiology ( September 2016 ) 23 ( Supplement 1 ), S38

Purposes: in cardiac rehabilitation (CR), increased cardiorespiratory fitness (CRF) is a desired and major outcome of CR. Assessing CRF by exercise testing at the initial assessment for the patient before entering a CR programme is strongly recommended in the guidelines. However, issues with the feasibility of using fitness testing tend to limit CRF assessment in clinical settings due to a lack of equipment, space, and skilled staff. The aim of this study is to investigate the ability of baseline characteristics to predict the distance walked during the Incremental Shuttle Walk Test (ISWT) in the cardiac rehabilitation population.
Methods: secondary analysis was conducted on the National Audit Cardiac Rehabilitation (NACR) data collected between 2010 and 2015. Patients were included in the analysis if they were adults (>18years) and had been assessed at baseline before they started CR and had a complete record of the ISWT. Stepwise regression was used to identify which factors can predict the distance covered during the ISWT. Age, gender, BMI, physical fitness assessment and pain assessment scales were the independent variables.  The first three variables were chosen based on the literature using different populations while the physical fitness assessment and pain assessment scales were the best self-reported perception variables available in the NACR data related to fitness and physical activity.  The ISWT distance was the dependent variable.
Results: A total of 10281 participants had completed the ISWT at the assessment baseline prior to starting a cardiac rehabilitation programme (7847 males and 2434 females). The participants’ mean age was 63+11.45 and ranged from 18 to 99 years. There were no significant differences in the mean age or BMI between males and females. The mean ISWT distance was 353.46m ± 176.74.  A stepwise regression analysis using age, gender and BMI explained 29% of the variance of the distance covered in the ISWT. This increased to 36% when pre-CR physical fitness and pain assessment variables were added (r = 0.60, R2 = 0.36, adjusted R2 = 0.36, SEE = 140.39, P < 0.001). Age was the best predictor explaining 20% of the variance. The remaining four variables: gender, the physical fitness scale, BMI, and pain assessment scale were significant predictors explaining 6%, 5%, 3%, and 2% of the variance respectively.
Conclusions: the ISWT is the most common CRF field test in CR centres in the UK. Age, gender and BMI, which are the most routinely measured in a clinical setting, were found to be the commonly determined key factors of fitness as defined by ISWT distance. The five predictors in this study explained 36% of the variance in the distance walked during ISWT. Of them, age was the best predictor.  However, a large proportion of the variance in walking distance remained unexplained, highlighting the complexity of predicting fitness as defined by ISWT distance.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are